Skip to main content
Mon-Sat: 8:30 - 20:30
Sun: 10:00 - 17:00
amarinichev@ngc.clinic
international@ngc.clinic

Understanding Embryo Grading: A Guide to Your IVF Embryo Report

You just received your embryo report from the IVF lab. The email says: "3 blastocysts — 5AA, 4BB, 3BC." You stare at the letters and numbers. What do they mean? Is 5AA perfect? Is 3BC a failure? Should you feel hopeful or worried?

Embryo grading can feel like receiving a school report card for something infinitely more important than math class. But here's what you need to know upfront: These grades are a helpful tool for selecting the embryo with the best potential for pregnancy, but they are not a guarantee or a verdict. Even "B" grade embryos lead to healthy pregnancies in 40-50% of cases.[1] Even "C" grade embryos sometimes result in beautiful, healthy babies. Conversely, an "AA" embryo can fail to implant for reasons unrelated to its appearance.

This guide explains what embryo grading is, how embryologists assess embryo quality, what the numbers and letters mean at day 3 and day 5, and—most importantly—what these grades mean for your IVF success rate. Our goal is clarity and reassurance, not anxiety.

What is Embryo Grading and Why is it Important?

Embryo grading is a visual assessment tool used by embryologists to evaluate the quality and developmental potential of embryos under a microscope. It's based on morphology—what the embryo looks like—not on its genetic makeup (we'll get to that limitation later).

Why do IVF labs grade embryos?

  1. To select the best embryo to transfer
    When you have multiple embryos, grading helps your fertility team decide which embryo has the highest likelihood of successful implantation and a healthy pregnancy. Modern practice increasingly favors single embryo transfer of the highest-grade embryo to reduce risks of multiples.[2]

  2. To decide which embryos are suitable for freezing (vitrification)
    Not all embryos survive the freeze-thaw process equally well. Higher-grade embryos generally tolerate vitrification (ultra-rapid freezing) better. Embryos that don't meet minimum quality thresholds may not be recommended for cryopreservation.

  3. To enable trophectoderm biopsy for preimplantation genetic testing
    If you're doing genetic testing (PGT-A or PGT-M), the embryo must reach the blastocyst stage (day 5 or later) and have sufficient trophectoderm cells for biopsy. Embryo grading helps identify which embryos are candidates for this procedure.[3]

    Important context: Embryo grading is somewhat subjective. Two embryologists might assign slightly different grades to the same embryo. However, most IVF clinics participate in proficiency testing programs and follow standardized grading systems (like the Gardner system for blastocysts) to ensure consistency.[4]

Day 3 Embryo Grading: The Cleavage Stage

At day 3 after retrieval and fertilization (or intracytoplasmic sperm injection, ICSI), the embryo is at the cleavage stage—a ball of dividing cells called blastomeres. Modern IVF practice increasingly favors extended culture to day 5 or day 6 to reach the blastocyst stage, but some clinics still assess and sometimes transfer day 3 embryos, especially if few embryos are available or in certain fertility situations.

Day 3 embryo grading typically evaluates two criteria:

Cell Number (The Best Indicator)

Cell number indicates the rate of embryo development. After 3 days, a healthy embryo should have divided into approximately 6-10 cells (ideally 8 cells on day 3).[5]

What cell number tells us:

  • Fewer than 6 cells: Slower development (lower potential)
  • 6-10 cells: Normal, on-track development (good potential)
  • More than 10 cells: Faster development (can be good, but rapid division sometimes indicates abnormalities)

Cell number is the single most predictive factor at day 3. An 8-cell embryo with slight fragmentation generally has better potential than a 5-cell embryo with perfect symmetry.

Embryo Grade (Cell Appearance)

The grade assesses two visual qualities:

  1. Fragmentation: Cellular debris between the cells. Fragmentation results from uneven cell division or cellular breakdown. Excessive fragmentation (>25%) correlates with lower implantation rates.[6]

2. Cell symmetry: Whether the cells (blastomeres) are evenly sized or irregular.

Grading systems for day 3 vary slightly between IVF clinics, but a common system uses Grade 1 through Grade 4 or Grade A through Grade C:

Grade

Fragmentation

Cell Symmetry

Quality Assessment

Grade A (or 1)

0-10%

Evenly sized cells

Excellent

Grade B (or 2)

10-25%

Slightly uneven cells

Good

Grade C (or 3)

25-50%

Uneven cells

Fair

Grade D (or 4)

>50%

Very uneven

Poor (rarely transferred)

Example: A day 3 embryo report might say "8-cell, Grade A" (8 evenly sized cells, minimal fragmentation) or "6-cell, Grade B" (6 cells with 15% fragmentation).

Why most IVF programs now prefer day 5 culture: Day 3 grading has limited predictive power. Many embryos that look good on day 3 arrest (stop developing) before day 5. Conversely, some day 3 embryos with imperfect morphology go on to form excellent blastocysts. Extended culture to the blastocyst stage provides far more information about developmental potential.

Day 5 Embryo Grading: The Blastocyst Stage

By day 5 (or sometimes day 6 or day 7), a healthy embryo has developed into a blastocyst—a complex structure of about 100-200 cells with distinct components. This is the stage at which embryo transfers occur either 3 days (rare now) or 5 days (standard) after retrieval, and when frozen ET (frozen embryo transfer) is most commonly performed after vitrification.[7]

Blastocyst grading uses the Gardner grading system, developed by David Gardner in 1999 and now the global standard.[8] The system evaluates three components of the embryo:

1. Expansion Grade (The Number: 1-6)

This number indicates how expanded the blastocyst is and whether an embryo is beginning to "hatch" from the zona pellucida (the protective shell).

Expansion Grade

Description

Stage

1

Early blastocystblastocoel (fluid cavity) is less than half the embryo

Early

2

Blastocystblastocoel fills half or more of the embryo

Developing

3

Full blastocystblastocoel completely fills the embryo

Full

4

Expanded blastocystblastocoel is larger than the embryo, zona pellucida is thinning

Expanded

5

Hatching blastocystembryo is beginning to break through the zona pellucida

Hatching

6

Hatched blastocystembryo has completely escaped the zona pellucida

Hatched

Important: Blastocysts are typically graded when they reach the blastocyst stage at expansion level 3 or higher. A grade 1 or 2 blastocyst on day 5 is considered slower-developing (though it might catch up by day 6).

2. Inner Cell Mass (ICM) Grade (The First Letter: A, B, C)

The inner cell mass (ICM) is the cluster of cells inside the blastocyst that will become the fetus. This is arguably the most important component for pregnancy potential.

ICM Grade

Description

Quality

A

Many cells, tightly packed, clearly defined

Excellent

B

Several cells, loosely grouped

Good

C

Very few cells, poorly defined

Fair/Poor

The ICM is graded because these cells directly form your baby. A strong, healthy ICM correlates with higher implantation rates and better pregnancy outcomes.[9]

3. Trophectoderm (TE) Grade (The Second Letter: A, B, C)

The trophectoderm (TE) is the outer layer of cells that will form the placenta and support structures. This layer is also biopsied during trophectoderm biopsy if you're doing preimplantation genetic testing for aneuploidy (PGT-A).[10]

TE Grade

Description

Quality

A

Many cells forming a cohesive, uniform layer

Excellent

B

Few cells, forming a loose layer

Good

C

Very few large, irregular cells

Fair/Poor

The trophectoderm is graded because a strong placenta is essential for nutrient delivery and a healthy pregnancy. Lower TE grades correlate with higher miscarriage risk even if the ICM is good.[11]

Putting It All Together: Interpreting Day 5 Blastocyst Grades

A day 5 embryo grade combines all three components: Expansion number + ICM letter + TE letter.

Example interpretations:

5AA — A hatching blastocyst with an excellent inner cell mass and excellent trophectoderm. This is considered a high-quality embryo with the highest potential for implantation and healthy pregnancy. Success rate: 60-70% per transfer.[1]

4BB — An expanded blastocyst with good ICM and good TE. This is a solid, high-quality embryo. Many healthy babies come from 4BB embryos. Success rate: 40-50% per transfer.[1]

4AB or 4BA — An expanded blastocyst with one component excellent (A) and one good (B). Still very strong. Success rate: 45-55% per transfer.

3BC — A full blastocyst with good ICM (B) but fair TE (C grade). This embryo has potential, especially if the ICM is strong, but the weaker TE suggests slightly lower odds. Success rate: 25-35% per transfer.[12]

3CC — A full blastocyst with both ICM and TE rated fair. Lower potential, but not hopeless. Some clinics may not freeze these; others will transfer if no better options exist. Success rate: 10-20% per transfer.

6AA — A fully hatched blastocyst with top grades. This sounds perfect, but embryos that hatch prematurely (too fast) sometimes have slightly lower success rates than grade 5AA because premature hatching can indicate chromosomal issues.[13]

Key takeaway: The embryo grading system helps assess the quality of embryos, but even "B" and "C" grade embryos result in healthy babies. Your embryologist and IVF specialists use grading alongside your fertility history and other factors to decide the optimal day of transfer and which embryo to select.

How Important is Embryo Grading for IVF Success Rates?

This is the question every IVF patient asks: "Will my embryo grade determine whether an embryo has good chances?"

The answer: Yes, but not absolutely.

Grading is a Strong Predictor, Not a Crystal Ball

Embryo grading correlates with pregnancy rates. Higher grades have higher success rates, but correlation is not causation. Here's why grading has limitations:

  1. Morphology ≠ Genetics
    Embryo grading is a tool based on appearance. But what you can't see under the microscope are chromosomal abnormalities (aneuploidy). A beautiful 5AA blastocyst might be chromosomally abnormal and fail to implant or miscarry. Conversely, a 4BC embryo might be chromosomally normal and result in a healthy baby.[14]

This is why preimplantation genetic testing (PGT-A) is increasingly common. PGT-A involves trophectoderm biopsy at the blastocyst stage, sending cells for chromosomal analysis. A chromosomally normal (euploid) embryo—even if it's graded 4BB—has better odds than an abnormal (aneuploid) 5AA embryo.[15]

2. Embryos Are Dynamic
An embryo graded 4BB on day 5 might have been graded 5AB if assessed 6 hours later. Development is continuous. A blastocyst that looks "fair" on day 5 might look "good" by day 6. This is why some clinics culture embryos to day 6 or even day 7 before making transfer or freezing decisions.

  1. Many Factors Beyond the Embryo Affect Success
    Successful pregnancy depends on:
  • Uterus receptivity (endometrial lining quality, timing of transfer)
  • Maternal age (impacts egg quality and chromosomal health)
  • Underlying fertility issues
  • Immune factors
  • Luck

Even with a perfect embryo, success is never 100%.

What the Data Shows

Large studies show clear trends in pregnancy rates by blastocyst grade:[1][16]

  • 5AA or 6AA: ~60-70% pregnancy rate per transfer
  • 4AA, 5AB, 5BA: ~50-60%
  • 4BB, 4AB, 4BA, 3AA: ~40-50%
  • 4BC, 3BB, 3AB: ~30-40%
  • 3BC, 3CC: ~20-30%
  • Lower grades: <20%

But notice: Even a 3BC embryo has a 1 in 4 chance of pregnancy. That's why IVF doctors don't automatically discard lower-grade embryos if they're your only option.

The Role of Preimplantation Genetic Testing (PGT)

If you're doing preimplantation genetic testing, the embryo grade becomes secondary to chromosomal status. Studies show that euploid (normal) embryos of grade 4BB have similar success rates to euploid embryos of grade 5AA—both around 60-65%.[17]

PGT-A involves:

  1. Culturing embryos to the blastocyst stage (day 5 or day 6)
  2. Performing trophectoderm biopsy (removing 5-10 cells from the TE layer)
  3. Freezing embryos via vitrification while cells are sent for analysis
  4. Transferring only euploid embryos in a subsequent frozen ET cycle

PGT-A is especially recommended for women over 37, recurrent miscarriage, or repeated IVF failure, as chromosomal abnormalities increase with maternal age.[18]

Glossary of Key Terms

Blastocyst: An embryo at day 5-7 of development, consisting of 100-200 cells with a fluid-filled cavity (blastocoel) and distinct inner cell mass and trophectoderm layers.

Inner Cell Mass (ICM): The cluster of cells inside the blastocyst that will develop into the fetus.

Trophectoderm (TE): The outer layer of the blastocyst that will form the placenta and supporting structures.

Fragmentation: Cellular debris or fragments between cells in an embryo, often a sign of cellular stress or abnormal development.

Vitrification: Ultra-rapid freezing technique used to preserve embryos for future use with minimal ice crystal formation.

Trophectoderm Biopsy: Removal of 5-10 cells from the trophectoderm layer of a blastocyst for genetic testing (PGT).

Euploid: An embryo with the correct number of chromosomes (46 in humans).

Aneuploid: An embryo with an abnormal number of chromosomes (too many or too few).

The Future of Embryo Grading: The Role of AI

Embryo grading has relied on human observation for decades, but the future is increasingly digital. Artificial Intelligence (AI) and machine learning are beginning to transform embryo quality assessment in IVF labs worldwide.[19]

How AI helps:

  1. Time-lapse imaging: Some IVF clinics, including Next Generation Clinic St. Petersburg, use time-lapse incubators that take photos of embryos every 10-15 minutes. AI algorithms analyze thousands of images to detect patterns invisible to the human eye—such as the exact timing of cell divisions, which correlates with implantation success.

  2. Objective grading: AI reduces subjectivity. Whether an embryo is graded BB or AB might vary between embryologists, but AI applies consistent criteria across all embryos.

  3. Predictive power: AI models trained on thousands of IVF cycles can predict likelihood of successful implantation and live birth more accurately than morphology alone.[20]

Important reassurance: AI is a tool to assist embryologists, not replace them. Human expertise in embryo development, patient history, and clinical judgment remains essential. Think of AI as a second opinion that helps your fertility team make even better decisions about which embryo to transfer.

Conclusion: Grades Are Guides, Not Guarantees

Understanding embryo grading is crucial for navigating your IVF treatment with realistic expectations and informed confidence. Here's what to remember:

  1. Embryo grades predict potential, not destiny.
    A 5AA embryo has excellent odds, but it's not guaranteed. A 3BC embryo has lower odds, but it can still work. Your embryo may surprise you.

  2. Modern IVF increasingly focuses on day 5-6 blastocysts.
    Extended culture to the blastocyst stage provides more information than day 3 assessment. Embryo transfers occur either 3 days or 5 days after retrieval, but day 5 is now standard in most IVF clinics.

  3. Morphology is only part of the picture.
    Genetic testing (PGT-A) provides insight that morphology can't: chromosomal health. A chromosomally normal embryo, even with a "B" grade, often outperforms an abnormal "A" grade embryo.

  4. Your fertility team uses grading alongside your history.
    Your age, fertility history, previous IVF cycles, and endometrial factors all play a role in selecting the best embryo for transfer and predicting IVF success.

The bottom line: Embryo grading is a powerful tool that helps IVF specialists assign a grade and select the embryo with the highest potential for implantation and a successful pregnancy. But even lower-graded embryos create families every day. Trust your fertility team, ask questions, and know that every grade—from AA to BC—has brought joy to someone.

The scientific supervisor reviewed the article

Lobzeva Diana

Senior Director of International Medical Affairs, OBGYN, Reproductive Endocrinologist


Make an appointment

Scientific References

[1] Gardner, D. K., Lane, M., Stevens, J., et al. (2000). Blastocyst score affects implantation and pregnancy outcome. Fertility and Sterility, 73(6), 1155-1158.

[2] Practice Committee of the American Society for Reproductive Medicine. (2017). Guidance on the limits to the number of embryos to transfer. Fertility and Sterility, 107(4), 901-903.

[3] Capalbo, A., Rienzi, L., Cimadomo, D., et al. (2014). Correlation between standard blastocyst morphology, euploidy and implantation. Reproductive BioMedicine Online, 28(3), 305-311.

[4] Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology. (2011). The Istanbul consensus workshop on embryo assessment. Human Reproduction, 26(6), 1270-1283.

[5] Scott, L. (2003). The biological basis of non-invasive strategies for selection of human oocytes and embryos. Human Reproduction Update, 9(3), 237-249.

[6] Alikani, M., Cohen, J., Tomkin, G., et al. (1999). Human embryo fragmentation in vitro and its implications for pregnancy and implantation. Fertility and Sterility, 71(5), 836-842.

[7] Roque, M., Haahr, T., Geber, S., et al. (2019). Fresh versus elective frozen embryo transfer in IVF/ICSI cycles: a systematic review and meta-analysis of reproductive outcomes. Human Reproduction Update, 25(1), 2-14.

[8] Gardner, D. K., & Schoolcraft, W. B. (1999). Culture and transfer of human blastocysts. Current Opinion in Obstetrics and Gynecology, 11(3), 307-311.

[9] Ahlstrom, A., Westin, C., Reismer, E., et al. (2011). Trophectoderm morphology: an important parameter for predicting live birth after single blastocyst transfer. Human Reproduction, 26(12), 3289-3296.

[10] Capalbo, A., Ubaldi, F. M., Rienzi, L., et al. (2013). Detecting mosaicism in trophectoderm biopsies. Fertility and Sterility, 100(4), 1031-1037.

[11] Van den Abbeel, E., Balaban, B., Ziebe, S., et al. (2013). Association between blastocyst morphology and outcome of single-blastocyst transfer. Reproductive BioMedicine Online, 27(4), 353-361.

[12] Irani, M., Reichman, D., Robles, A., et al. (2017). Morphologic grading of euploid blastocysts influences implantation and ongoing pregnancy rates. Fertility and Sterility, 107(3), 664-670.

[13] Bodri, D., Sugimoto, T., Serna, J. Y., et al. (2016). Influence of different oocyte insemination techniques on early and late morphokinetic parameters. Fertility and Sterility, 106(5), 1175-1181.

[14] Alfarawati, S., Fragouli, E., Colls, P., et al. (2011). The relationship between blastocyst morphology, chromosomal abnormality, and embryo gender. Fertility and Sterility, 95(2), 520-524.

[15] Rubio, C., Bellver, J., Rodrigo, L., et al. (2017). In vitro fertilization with preimplantation genetic diagnosis for aneuploidies in advanced maternal age: a randomized, controlled study. Fertility and Sterility, 107(5), 1122-1129.

[16] Schoolcraft, W. B., Gardner, D. K., Lane, M., et al. (1999). Blastocyst culture and transfer: analysis of results and parameters affecting outcome in two in vitro fertilization programs. Fertility and Sterility, 72(4), 604-609.

[17] Irani, M., O'Neill, C., Palermo, G. D., et al. (2018). Blastocyst development rate influences implantation and live birth rates of similarly graded euploid blastocysts. Fertility and Sterility, 110(1), 95-102.

[18] Franasiak, J. M., Forman, E. J., Hong, K. H., et al. (2014). The nature of aneuploidy with increasing age of the female partner. Fertility and Sterility, 101(3), 656-663.

[19] VerMilyea, M., Hall, J. M. M., Diakiw, S. M., et al. (2020). Development of an artificial intelligence-based assessment model for prediction of embryo viability using static images captured by optical light microscopy during IVF. Human Reproduction, 35(4), 770-784.

[20] Tran, D., Cooke, S., Illingworth, P. J., et al. (2019). Deep learning as a predictive tool for fetal heart pregnancy following time-lapse incubation and blastocyst transfer. Human Reproduction, 34(6), 1011-1018.